Adding arthritis drug baricitinib to remdesivir may reduce recovery time in adult patients hospitalized with COVID-19, according to a study. Scientists and healthcare professionals are working hard to find the best treatment that might benefit patients hospitalized with SARS-CoV-2. In a previous study, researchers observed that the remdesivir, an antiviral drug, was effective in patients […]
The post Baricitinib and remdesivir for patients with COVID-19 appeared first on Medical News Bulletin | Health News and Medical Research.
